An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment
Condition(s):Tuberculosis; Drug-resistant Tuberculosis; Adherence, Medication; Adherence, PatientLast Updated:July 28, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Tuberculosis; Drug-resistant Tuberculosis; Adherence, Medication; Adherence, PatientLast Updated:July 28, 2021Completed
Condition(s):TuberculosisLast Updated:September 22, 2005Unknown status
Condition(s):Tuberculosis; Thoracic Surgery; Tuberculosis, Pulmonary; Tuberculosis, Multidrug-ResistantLast Updated:March 1, 2024Active, not recruiting
Condition(s):TuberculosisLast Updated:April 20, 2017Terminated
Condition(s):Multidrug- and Rifampicin-resistant TuberculosisLast Updated:March 15, 2024Recruiting
Condition(s):Tuberculosis; Drug-resistant Tuberculosis; Isoniazid Resistant Tuberculosis (Disorder)Last Updated:October 19, 2020Completed
Condition(s):Tuberculosis; Human Immunodeficiency VirusLast Updated:August 25, 2023Recruiting
Condition(s):Tuberculosis, PulmonaryLast Updated:June 28, 2011Completed
Condition(s):Tuberculosis, Pulmonary; Tuberculosis, Multidrug-Resistant; Tuberculosis, MDR; Tuberculosis; Drug-Resistant TuberculosisLast Updated:March 7, 2024Completed
Condition(s):Pulmonary Tuberculosis Suspected; Other Specified Chronic Obstructive Pulmonary Disease; Pulmonary Tuberculosis TB (+) Histology, (-) BacteriologyLast Updated:June 1, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.